Pfizer
Trade Pfizer 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About PFE
Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases.
PFE Key Statistics
Stock Snapshot
Pfizer(PFE) stock is priced at $25.25, giving the company a market capitalization of 143.22B. It carries a P/E multiple of 14.60 and pays a dividend yield of 6.9%.
As of 2025-12-19, Pfizer(PFE) stock has fluctuated between $24.98 and $25.52. The current price stands at $25.25, placing the stock +1.1% above today's low and -1.1% off the high.
Pfizer(PFE) shares are trading with a volume of 87.59M, against a daily average of 54.73M.
In the last year, Pfizer(PFE) shares hit a 52-week high of $27.69 and a 52-week low of $20.92.
In the last year, Pfizer(PFE) shares hit a 52-week high of $27.69 and a 52-week low of $20.92.
PFE News
This year has been one to forget for these pharmaceutical giants. Pfizer (PFE +0.54%) and Merck (MRK +0.17%) are two pharmaceutical giants that have lagged bro...
Astellas Pharma and Pfizer recently reported that their Phase 3 EV-304 trial of PADCEV plus Keytruda in muscle-invasive bladder cancer met key efficacy and safe...
Pfizer Inc (PFE) announced an update on their ongoing clinical study. Claim 50% Off TipRanks Premium and Invest with Confidence Unlock hedge-fund level data and...
Analyst ratings
57%
of 28 ratingsMore PFE News
Pfizer's shares look attractive to investors willing to show patience. Stock investors have many options to choose among, of course. These include individual e...
The U.S. Food and Drug Administration (FDA) has approved a label change for Pfizer Inc.'s (NYSE:PFE) Depo-Provera contraceptive injection, adding a warning abou...
Pfizer Inc (NYSE:PFE) and Merck & Co Inc (NYSE:MRK) aren't exciting stocks anymore — and after a bruising reset, that's starting to look intentional. Pfizer's s...
Key Points Pfizer has a substantial 6.6% dividend yield but a payout ratio exceeding 100%. Eli Lilly has a payout ratio of roughly 30%, but its dividend yield...
Astellas Pharma (ALPMY) and Pfizer (PFE) announced topline results from an interim analysis of the Phase 3 EV-304 clinical trial for Padcev, a Nectin-4 directed...
Courtney Breen, an analyst from Bernstein, maintained the Hold rating on Pfizer. The associated price target remains the same with $30.00. Claim 50% Off TipRank...
Pfizer (NYSE:PFE), which develops and sells biopharmaceutical products worldwide, closed today's session (Dec. 16) at $25.53, down 3.41%. Trading volume reached...